BioSpace News Archive

Pharm Country

TYME Technologies, Inc. Provides Update on Precision Promise Trial in Metastatic Pancreatic Cancer

TYME Technologies, Inc. today announced the discontinuation of SM-88 with MPS in the Precision Promise trial in metastatic pancreatic cancer.

January 26, 2022
·
8 min read
Biotech Beach

Recro Wins $1.5 Million Formulation Development and CGMP Manufacturing Contract to Support Clinical Development of Topical Treatment for Skin Cancer Prevention

Recro Pharma, Inc. today announced that it has been awarded a new formulation development and cGMP manufacturing contract from a key department of the United States government.

January 26, 2022
·
4 min read
Lone Star Bio

Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos Therapeutics

Ziopharm Oncology, Inc. today highlighted recent operational and corporate updates.

January 26, 2022
·
7 min read
Business

Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors

Ikena Oncology, Inc. today announced the appointment of Richard Wooster, Ph.D., to its Board of Directors.

January 26, 2022
·
4 min read
Canadian study reinforces need for hip fracture prevention strategies to help reduce future fracture risks and their associated costs

Study results align with United Nations’ focus on maintaining functional independence, reinforces call for better integrated care to prevent hip fractures.

January 26, 2022
·
9 min read
Pharm Country

Quest Diagnostics Launches COVID-19 Rapid Antigen Test with Observed Collection for Consumers Through QuestDirect™

Quest Diagnostics today announced the availability of an at-home COVID-19 rapid antigen test service for consumer purchase, available through QuestDirect™, the company’s consumer-initiated testing platform.

January 26, 2022
·
5 min read
Drug Development

Silence Therapeutics Announces SLN360 Phase 1 Data Accepted for Late-Breaking Presentation at the American College of Cardiology (ACC) Annual Scientific Session and Expo

Silence Therapeutics plc today announced the acceptance of a late-breaking clinical abstract on the ongoing SLN360.

January 26, 2022
·
4 min read
Business

BrainsWay Announces Addition of Markus Heilig, M.D., Ph.D., to Scientific Advisory Board

BrainsWay Ltd., a global leader in the advanced noninvasive treatment of brain disorders, announced the addition of Professor Markus Heilig, M.D., Ph.D., to BrainsWay’s scientific advisory board.

January 26, 2022
·
5 min read
AIM ImmunoTech to Participate in a Solve M.E. Diagnostics and Treatments Webinar

AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), today announced it will participate in the Solve M.E. Diagnostics and Treatments Webinar: “Ampligen: A General Overview and the Plan for ME/CFS & Long Covid,” being held on Thursday, January 27, 2022 from 2:00 – 3:00 pm ET.

January 26, 2022
·
3 min read
Drug Development

Cyclerion Therapeutics Announces Initiation of Patient Dosing in CY6463 Phase 2a Study in Alzheimer’s Disease with Vascular Pathology

Cyclerion Therapeutics, Inc. today announced that patient dosing has begun in its Phase 2a study in Alzheimer’s Disease with Vascular Pathology (ADv).

January 26, 2022
·
5 min read